No Data
No Data
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Cuts Target Price to $28
Bears Are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now
Shareholders in OrthoPediatrics (NASDAQ:KIDS) Have Lost 58%, as Stock Drops 7.6% This Past Week
Express News | JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $50 Price Target
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
No Data
No Data